5-HT7, neurogenesis and antidepressants: A promising therapeutic axis for treating depression

Clinical and Experimental Pharmacology and Physiology

Volumn 34, Issue 5-6, 2007, Pages 546-551

  Nandam, L Sanjay ^a,b   Jhaveri, Dhanisha ^a   Bartlett, Perry ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

5 HT7; Antidepressants; Depression; Hippocampus; Neural precursor; Neurogenesis; Proliferation; Serotonin; Subventricular zone

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; 2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ANTIDEPRESSANT AGENT; CILIARY NEUROTROPHIC FACTOR; CLOZAPINE; DIZOCILPINE; FENCLONINE; FIBROBLAST GROWTH FACTOR 2; FLUOXETINE; GR 127395; HALOPERIDOL; ISOTRETINOIN; KETANSERIN; LITHIUM; METHAMPHETAMINE; MORPHINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROPEPTIDE Y; OLANZAPINE; QUETIAPINE; REBOXETINE; RIMONABANT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; THYROXINE; TIANEPTINE; TRANYLCYPROMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; SEROTONIN 7 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

BRAIN DEPTH STIMULATION; DEPRESSION; DRUG POTENTIATION; HIPPOCAMPUS; MOLECULAR DYNAMICS; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; RECEPTOR BINDING; REVIEW; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; HUMAN; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTIDEPRESSIVE AGENTS; CELL DIFFERENTIATION; DEPRESSIVE DISORDER; HIPPOCAMPUS; HUMANS; NEURONS; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 33947676942     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04608.x     Document Type: Review

References (63)

1. Duman RS, Nakagawa S, Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 2001; 25: 836-44.
2. McEwen BS. Stress and the aging hippocampus. Front. Neuroendocrinol. 1999; 20: 49-70.
3. Gould E, McEwen BS, Tanapat P, Galea LA, Fuchs E. Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J. Neurosci. 1997; 17: 2492-8.
4. Sapolsky RM. Is impaired neurogenesis relevant to the affective symptoms of depression? Biol. Psychiatry 2004; 56: 137-9.
5. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc. Natl Acad. Sci. USA 1996; 93: 3908-13.
6. Kanner AM. Structural MRI changes of the brain in depression. Clin. EEG Neurosci. 2004; 35: 46-52.
7. McEwen BS. Glucocorticoids, depression, and mood disorders: Structural remodeling in the brain. Metabolism 2005; 54: 20-3.
8. Hickie I, Naismith S, Ward PB et al. Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression. Br. J. Psychiatry 2005; 186: 197-202.
9. Tanapat P, Galea LA, Gould E. Stress inhibits the proliferation of granule cell precursors in the developing dentate gyrus. Int. J. Dev. Neurosci. 1998; 16: 235-9.
10. Pham K, Nacher J, Hof PR, McEwen BS. Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. Eur. J. Neurosci. 2003; 17: 879-86.
11. Gould E, Tanapat P, Rydel T, Hastings N. Regulation of hippocampal neurogenesis in adulthood. Biol. Psychiatry 2000; 48: 715-20.
12. Swann A, O'Brien J, Ames D, Schweitzer I, Desmond P, Tress B. Does hippocampal atrophy on MRI predict cognitive decline? A prospective follow-up study. Int. J. Geriatr. Psychiatry 1997; 12: 1182-8.
13. Sheline YI. Neuroimaging studies of mood disorder effects on the brain. Biol. Psychiatry 2003; 54: 338-52.
14. Mucignat-Caretta C, Bondi M, Caretta A. Animal models of depression: Olfactory lesions affect amygdala, subventricular zone, and aggression. Neurobiol. Dis. 2004; 16: 386-95.
15. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 2000; 20: 9104-10.
16. Ambrogini P, Cuppini R, Ferri P et al. Thyroid hormones affect neurogenesis in the dentate gyrus of adult rat. Neuroendocrinology 2005; 81: 244-53.
17. Czeh B, Michaelis T, Watanabe T et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc. Natl Acad. Sci. USA 2001; 98: 12 796-801.
18. van Praag H, Kempermann G, Gage FH. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat. Neurosci. 1999; 2: 266-70.
19. Chen G, Rajkowska G, Du F, Seraji-Bozorgzad N, Manji HK. Enhancement of hippocampal neurogenesis by lithium. J. Neurochem. 2000; 75: 1729-34.
20. Santarelli L, Saxe M, Gross C et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003; 301: 805-9.
21. Wakade CG, Mahadik SP, Waller JL, Chiu FC. Atypical neuroleptics stimulate neurogenesis in adult rat brain. J. Neurosci. Res. 2002; 69: 72-9.
22. Halim ND, Weickert CS, McClintock BW, Weinberger DR, Lipska BK. Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus. Neuropsychopharmacology 2004; 29: 1063-9.
23. Xu H, Chen Z, He J et al. Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus 2006; 16: 551-9.
24. Teuchert-Noodt G, Dawirs RR, Hildebrandt K. Adult treatment with methamphetamine transiently decreases dentate granule cell proliferation in the gerbil hippocampus. J. Neural Transm. 2000; 107: 133-43.
25. Kuhn HG, Winkler J, Kempermann G, Thal LJ, Gage FH. Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J. Neurosci. 1997; 17: 5820-9.
26. Aberg MA, Aberg ND, Hedbacker H, Oscarsson J, Eriksson PS. Peripheral infusion of IGF-1 selectively induces neurogenesis in the adult rat hippocampus. J. Neurosci. 2000; 20: 2896-903.
27. Emsley JG, Hagg T. Endogenous and exogenous ciliary neurotrophic factor enhances forebrain neurogenesis in adult mice. Exp. Neurol. 2003; 183: 298-310.
28. Cameron HA, Gould E. Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus. Neuroscience 1994; 61: 203-9.
29. Shingo T, Gregg C, Enwere E et al. Pregnancy-stimulated neurogenesis in the adult female forebrain mediated by prolactin. Science 2003; 299: 117-20.
30. Jin K, Xie L, Kim SH et al. Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. Mol. Pharmacol. 2004; 66: 204-8.
31. Van Kampen JM, Hagg T, Robertson HA. Induction of neurogenesis in the adult rat subventricular zone and neostriatum following dopamine D receptor stimulation. Eur. J. Neurosci. 2004; 19: 2377-87.
32. Crandall J, Sakai Y, Zhang J et al. 13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice. Proc. Natl Acad. Sci. USA 2004; 101: 5111-16.
33. Bauer S, Moyse E, Jourdan F, Colpaert F, Martel JC, Marien M. Effects of the alpha 2-adrenoreceptor antagonist dexefaroxan on neurogenesis in the olfactory bulb of the adult rat in vivo: Selective protection against neuronal death. Neuroscience 2003; 117: 281-91.
34. Kitayama T, Yoneyama M, Tamaki K, Yoneda Y. Regulation of neuronal differentiation by N-methyl-D-aspartate receptors expressed in neural progenitor cells isolated from adult mouse hippocampus. J. Neurosci. Res. 2004; 76: 599-612.
35. Morcuende S, Gadd CA, Peters M et al. Increased neurogenesis and brain-derived neurotrophic factor in neurokinin-1 receptor gene knockout mice. Eur. J. Neurosci. 2003; 18: 1828-36.
36. Howell OW, Scharfman HE, Herzog H, Sundstrom LE, Beck-Sickinger A, Gray WP. Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells. J. Neurochem. 2003; 86: 646-59.
37. Malberg JE, Duman RS. Cell proliferation in adult hippocampus is decreased by inescapable stress: Reversal by fluoxetine treatment. Neuropsychopharmacology 2003; 28: 1562-71.
38. 7 receptor research. Trends Pharmacol. Sci. 2004; 25: 481-6.
39. Willner P. Antidepressants and serotonergic neurotransmission: An integrative review. Psychopharmacology (Berl.) 1985; 85: 387-404.
40. Bonhomme N, Esposito E. Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: A review. J. Clin. Psychopharmacol. 1998; 18: 447-54.
41. McQuade R, Sharp T. Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis. J. Neurochem. 1997; 69: 791-6.
42. Brezun JM, Daszuta A. Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats. Neuroscience 1999; 89: 999-1002.
43. Banasr M, Hery M, Printemps R, Daszuta A. Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone. Neuropsychopharmacology 2004; 29: 450-60.
44. Radley JJ, Jacobs BL. 5-HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus. Brain Res. 2002; 955: 264-7.
45. Gardier AM, Malagie I, Trillat AC, Jacquot C, Artigas F. Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: Recent findings from in vivo microdialysis studies. Fundam. Clin. Pharmacol. 1996; 10: 16-27.
46. Cryan JF, Leonard BE. 5-HT1A and beyond: The role of serotonin and its receptors in depression and the antidepressant response. Hum. Psychopharmacol. 2000; 15: 113-35.
47. Blier P, Ward NM. Is there a role for 5-HT1A agonists in the treatment of depression? Biol. Psychiatry 2003; 53: 193-203.
48. 7 receptors. Curr. Drug Targets CNS Neurol. Disord. 2004; 3: 81-90.
49. 3H]mesulergine: Comparison to other mammalian species. Br. J. Pharmacol. 2004; 141: 92-104.
50. 3H]8-hydroxy-2-(di-n-propylamino) tetraline: Analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice. J. Pharmacol. Exp. Ther. 2002; 302: 240-8.
51. Garcia-Alcocer G, Segura LC, Garcia Pena M, Martinez-Torres A, Miledi R. Ontogenetic distribution of 5-HT2C, 5-HT5A, and 5-HT7 receptors in the rat hippocampus. Gene Expr. 2006; 13: 53-7.
52. Le Bon O, Staner L, Murphy JR, Hoffmann G, Pull CH, Pelc I. Critical analysis of the theories advanced to explain short REM sleep latencies and other sleep anomalies in several psychiatric conditions. J Psychiatr. Res. 1997; 31: 433-50.
53. 7 receptor regulation in the rat hypothalamus. Neuropsychopharmacology 1999; 21: 352-67.
54. 7 receptor antagonist, modulates REM sleep in rats. Br. J. Pharmacol. 2003; 139: 705-14.
55. Hedlund PB, Huitron-Resendiz S, Henriksen SJ, Sutcliffe JG. 5-HT7 receptor inhibition and inactivation induce antidepressant-like behavior and sleep pattern. Biol. Psychiatry 2005; 58: 831-7.
56. Hairston IS, Little MT, Scanlon MD et al. Sleep restriction suppresses neurogenesis induced by hippocampus-dependent learning. J. Neurophysiol. 2005; 94: 4224-33.
57. 7 receptor. Brain Res. Dev. Brain Res. 2002; 139: 199-203.
58. 7 receptor gene expression in the rat hippocampus. Brain Res. Mol. Brain Res. 1997; 45: 182-6.
59. 7 receptor suggest therapeutic potential in depression. Neuropharmacology 2005; 48: 492-502.
60. 7 receptor-mediated effects on 5-HT efflux in the guinea-pig dorsal raphe nucleus. Neuropharmacology 2004; 46: 935-41.
61. 7 receptors. Naunyn Schmiedebergs Arch. Pharmacol. 2000; 362: 284-9.
62. 7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology. J. Neurosci. 2005; 25: 7821-30.
63. Kodama M, Fujioka T, Duman RS. Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol. Psychiatry 2004; 56: 570-80.